Combination of stromal vascular fraction and Ad‑COMP‑Ang1 gene therapy improves long‑term therapeutic efficacy for diabetes‑induced erectile dysfunction
Combination of stromal vascular fraction and Ad‑COMP‑Ang1 gene therapy improves long‑term therapeutic efficacy for diabetes‑induced erectile dysfunction
复制标题
基质血管部分和 Ad-COMP-Ang1 基因疗法的组合可提高糖尿病引起的勃起功能障碍的长期治疗效果
DOI:
--
复制
发表时间:
2018
影响因子:
2.9
通讯作者:
Hai‑Rong Jin
中科院分区:
文献类型:
--
作者:
Guo-Nan Yin;Lin Wang;Xiang-Nan Lin;Lei Shi;Zhen-Lin Gao;Feng-Chan Han;Ping Li;Yin-Chuan Jin;Jun‑Kyu Suh;Ji‑Kan Ryu;Xiong Wang;Hai‑Rong Jin
Men with diabetic erectile dysfunction (ED) respond poorly to the currently available oral phosphodiesterase‑5 inhibitors..Therefore, functional therapies for diabetic ED are needed. Stromal vascular fraction (SVF) and the adenovirus‑mediated cartilage.oligomeric matrix angiopoietin‑1 (Ad‑COMP‑Ang1) gene are known to play critical roles in penile erection. We previously reported.that SVF and Ad‑COMP‑Ang1 have only a short‑term effect in restoring erectile function. Further improvements to ED therapy.are needed for long‑lasting effects. In the present study, we aimed to test if the combination of SVF and Ad‑COMP‑Ang1 could.extend the erection effect in diabetic ED. We found that the combination therapy showed a long‑term effect in restoring erectile.function through enhanced penile endothelial and neural cell regeneration. Combination therapy with SVF and Ad‑COMP‑Ang1.notably restored cavernous endothelial cell numbers, pericyte numbers, endothelial cell–cell junctions, decreased cavernous.endothelial cell permeability, and promoted neural regeneration for at least 4 weeks in diabetic mice. In summary, this is an.initial description of the long‑term effect of combination therapy with SVF and Ad‑COMP‑Ang1 in restoring erectile function.through a dual effect on endothelial and neural cell regeneration. Such combination therapy may have therapeutic potential.for the treatment of diabetic ED.